Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Oxitriptan 50mg capsules
0403040R0AAAFAF
|
Oxitriptan | Oxitriptan | Central Nervous System | No data available |
|
Oxitriptan 50mg modified-release tablets
0403040R0AAAKAK
|
Oxitriptan | Oxitriptan | Central Nervous System | No data available |
|
Oxitropium bromide 100micrograms/dose BA inhaler
0301020P0AAABAB
|
Oxitropium bromide | Oxitropium bromide | Respiratory System | No data available |
|
Oxitropium bromide 100micrograms/dose inhaler
0301020P0AAAAAA
|
Oxitropium bromide | Oxitropium bromide | Respiratory System | No data available |
|
Oxivent 100micrograms/dose Autohaler
0301020P0BBABAB
|
Oxivent | Oxitropium bromide | Respiratory System | No data available |
|
Oxivent 100micrograms/dose inhaler
0301020P0BBAAAA
|
Oxivent | Oxitropium bromide | Respiratory System | No data available |
|
Oxprenolol 160mg modified-release tablets
0204000N0AAAFAF
|
Oxprenolol hydrochloride | Oxprenolol hydrochloride | Cardiovascular System | No data available |
|
Oxprenolol 20mg tablets
0204000N0AAABAB
|
Oxprenolol hydrochloride | Oxprenolol hydrochloride | Cardiovascular System | No data available |
|
Oxprenolol 40mg tablets
0204000N0AAACAC
|
Oxprenolol hydrochloride | Oxprenolol hydrochloride | Cardiovascular System | No data available |
|
Oxprenolol 80mg tablets
0204000N0AAADAD
|
Oxprenolol hydrochloride | Oxprenolol hydrochloride | Cardiovascular System | No data available |
|
Oxprenolol 80mg/5ml oral solution
0204000N0AAALAL
|
Oxprenolol hydrochloride | Oxprenolol hydrochloride | Cardiovascular System | No data available |
|
Oxy 10 lotion
1306010C0BJAAAI
|
Oxy (Cream/Lotion) | Benzoyl peroxide | Skin | No data available |
|
Oxy 5 lotion
1306010C0BJABAH
|
Oxy (Cream/Lotion) | Benzoyl peroxide | Skin | No data available |
|
Oxy On-the-Spot 2.5% cream
1306010C0BJADAZ
|
Oxy (Cream/Lotion) | Benzoyl peroxide | Skin | No data available |
|
Oxyargin 10mg/5mg modified-release tablets
0407020AFBDABAA
|
Oxyargin | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Oxyargin 20mg/10mg modified-release tablets
0407020AFBDACAB
|
Oxyargin | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Oxybutynin 10mg/10ml intravesical solution pfs
0704040G0AAAHAH
|
Oxybutynin hydrochloride (Bladder) | Oxybutynin hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Oxybutynin 12.5mg/5ml oral solution
0704020J0AAARAR
|
Oxybutynin (Systemic) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Oxybutynin 3mg/5ml oral solution
0704020J0AAALAL
|
Oxybutynin (Systemic) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Oxybutynin 3mg/5ml oral suspension
0704020J0AAAYAY
|
Oxybutynin (Systemic) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Oxybutynin 5mg/15ml bladder irrigation vials
0704040G0AAAGAG
|
Oxybutynin hydrochloride (Bladder) | Oxybutynin hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Oxybutynin 5mg/30ml bladder irrigation pre-filled syringes
0704040G0AAADAD
|
Oxybutynin hydrochloride (Bladder) | Oxybutynin hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Oxybutynin 5mg/30ml bladder irrigation vials
0704040G0AAABAB
|
Oxybutynin hydrochloride (Bladder) | Oxybutynin hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Oxybutynin 8mg/5ml oral solution
0704020J0AAAPAP
|
Oxybutynin (Systemic) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Oxycodone 30mg suppositories
0407020Z0AAAAAA
|
Oxycodone | Oxycodone | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.